Director/PDMR Shareholding

RNS Number : 3554Q
GlaxoSmithKline PLC
11 October 2013
 



 

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 11 October 2013 of the following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1546.50 pence per Ordinary Share and $50.22 per ADS following the re-investment of dividends paid to shareholders on 3 October 2013.

 

 

Sir Andrew Witty

Acquisition of 1,417 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 1,417 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S Dingemans

Acquisition of 508 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 508 Ordinary Shares under the matching element of the Plan (Company contribution).



Dr M M Slaoui

Acquisition of 647 ADSs under the personal contribution element of the Plan.




Acquisition of 647 ADSs under the matching element of the Plan (Company contribution).



Mr S M Bicknell

Acquisition of 213 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 213 Ordinary Shares under the matching element of the Plan (Company contribution).



Mrs D P Connelly

Acquisition of 115 ADSs under the personal contribution element of the Plan.




Acquisition of 115 ADSs under the matching element of the Plan (Company contribution).



Mr R G Connor

Acquisition of 58 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 58 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr W C Louv

Acquisition of 95 ADSs under the personal contribution element of the Plan.




Acquisition of 95 ADSs under the matching element of the Plan (Company contribution).



Mr D S Redfern

Acquisition of 335 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 335 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms C Thomas 

Acquisition of 215 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 215 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr P C Thomson

Acquisition of 11 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 11 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr D E Troy

Acquisition of 306 ADSs under the personal contribution element of the Plan.




Acquisition of 306 ADSs under the matching element of the Plan (Company contribution).



Dr P J T Vallance

Acquisition of 713 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 713 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms E Walmsley

Acquisition of 284 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 284 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

S M Bicknell

Company Secretary

 

11 October 2013

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFFXBFFFBZ

Companies

GSK (GSK)
UK 100